The inhalation route delivers medication directly into the respiratory tract, allowing drugs to act locally in the airways or enter the systemic circulation rapidly. Because the lungs possess an enormous surface area and a rich blood supply, inhaled substances bypass the hepatic first-pass metabolism entirely. This route achieves a rapid onset of action compared to oral administration, making it invaluable for managing acute respiratory distress, bronchospasm, and chronic conditions like asthma or chronic obstructive pulmonary disease. Understanding how these agents traverse mucosal barriers forms the foundation of safe respiratory pharmacology.
A successful inhalation therapy depends heavily on particle size and respiratory tract architecture. As air travels downward, the airway passages narrow and branch extensively, creating different zones of particle deposition:
Patients with obstructed airways often trap larger particles prematurely in the mouth and throat rather than reaching the targeted lower lung tissues.
Various delivery systems convert liquid or solid medications into respirable aerosols. Choosing the correct device ensures optimal drug delivery to the lungs.
Incorrect device handling remains a primary reason for treatment failure in clinical practice.
Inhalation therapy treats both acute bronchoconstriction and long-term inflammatory lung diseases. Bronchodilators relax the smooth muscles surrounding the bronchioles, instantly relieving wheezing and shortness of breath. Corticosteroids reduce chronic airway inflammation and mucosal edema over time. Anticholinergics block parasympathetic bronchoconstriction, proving particularly useful in chronic bronchitis and emphysema. Nurses must distinguish between fast-acting rescue medications and long-term controller medications to educate patients effectively.
Before administering any inhaled medication, the nurse assesses the patient's baseline respiratory status, including respiratory rate, breath sounds, oxygen saturation, and work of breathing. Assessing cognitive ability and manual dexterity helps determine if the patient can operate a specific device independently. A patient with severe hand tremors or cognitive impairment will struggle with a standard metered-dose inhaler and may require a nebulizer or caregiver assistance. Nurses also verify whether the patient used recent rescue medications and check the oral cavity for signs of fungal infections.
Proper technique dictates therapeutic success. For a metered-dose inhaler, the nurse instructs the patient to shake the canister, exhale completely, place the mouthpiece securely between the teeth and lips, press down while starting a slow, deep inhalation, and hold the breath for ten seconds before exhaling slowly. When administering inhaled corticosteroids, rinsing the mouth with water and spitting it out is mandatory to prevent oral candidiasis and hoarseness. Providing a physical demonstration and having the patient return the demonstration ensures safe administration at home.
Although inhalation limits systemic exposure compared to oral or intravenous routes, local and systemic adverse effects still occur. Frequent use of beta-agonist rescue inhalers can cause tachycardia, palpitations, tremors, and nervousness. Improper cleaning of nebulizer equipment introduces bacterial or fungal pathogens directly into the lower respiratory tract, risking severe pneumonia. Nurses must educate patients on regular device maintenance, recognizing worsening symptoms, and seeking prompt medical attention if rescue medications fail to relieve acute distress.